Results 231 to 240 of about 15,790 (257)
Some of the next articles are maybe not open access.
Hyperthermic Intraperitoneal Chemotherapy
Advances in Anesthesia, 2005Cancer treatment frequently requires a multimodality approach, involving surgical resection(s), radiotherapy, and chemotherapy. Advanced surgical approaches allow for the combination of two of these, offering patients intraoperative radiotherapy with surgical resection or intraoperative chemotherapy targeted and limited to a particular body region. The
Thomas B. Dougherty, Alicia M. Kowalski
openaire +2 more sources
Peritoneal Cancers and Hyperthermic Intraperitoneal Chemotherapy
Surgical Clinics of North America, 2020Cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy is an aggressive, potentially curative approach used to treat locoregional disease associated with primary and secondary malignancies of the peritoneum. It involves resection of all macroscopic disease larger than 2.5 mm, followed by instillation of hyperthermic chemotherapy ...
Eric Pletcher +2 more
openaire +3 more sources
Hyperthermic Intraperitoneal Chemotherapy
Surgical Oncology Clinics of North America, 2012Several methods of delivering hyperthermic intraperitoneal chemotherapy (HIPEC) during the course of cytoreductive surgery have been described, but no significant differences in treatment results have been found among them. HIPEC is a safe treatment for the patient and for healthcare workers involved in the procedure provided standard protective and ...
Gloria Ortega-Pérez +3 more
openaire +3 more sources
Hyperthermic intraperitoneal chemotherapy for treating ovarian cancer
JAAPA, 2021ABSTRACT Hyperthermic intraperitoneal chemotherapy (HIPEC) has been used for decades as a treatment for disseminated abdominal malignancies, including pseudomyxoma peritonei and peritoneal mesothelioma. HIPEC had been used to treat recurrent ovarian cancer only when curative options were lacking, but new data indicate that it may be suitable ...
Rose Dorian +4 more
openaire +2 more sources
Hyperthermic intraperitoneal chemotherapy in ovarian cancer: an update
Hormone Molecular Biology and Clinical Investigation, 2020Abstract In the treatment of advanced-stage epithelial ovarian cancer (EOC)-associated surgery and chemotherapy with intravenous platinum/taxane-based therapy most patients had early or late recurrence. Prevention of progression and recurrence is a major objective for the management of EOC.
Aurélie Revaux +7 more
openaire +4 more sources
Hyperthermic Intraperitoneal Chemotherapy
2017Peritoneal metastasis in abdominal malignancies is associated with a dismal prognosis. In the past, it was considered inoperable and the patient was considered a candidate for palliative chemotherapy alone. The outcome of systemic chemotherapy is poor with the average survival being 6–8 months.
Nikhil Gupta, Shivendra Singh
openaire +2 more sources
Selection of Chemotherapy in Hyperthermic Intraperitoneal Chemotherapy
2017The peritoneum consists of a layer of mesothelial cells covering all abdominal organs and the abdominopelvic wall. Peritoneal metastases are formed after exfoliation of free tumor cells from a primary tumor invading the peritoneum. Consequently, most peritoneal metastases originate from abdominal organs such as the colon, rectum, stomach, or ovaria ...
H. J. Braam, F. J. H. Hoogwater
openaire +2 more sources
Ventricular tachycardia during hyperthermic intraperitoneal chemotherapy
Anaesthesia, 2009SummaryCytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC) is used for selected gastrointestinal carcinomas. We report a case of ventricular tachycardia during HIPEC with cisplatin that persisted as long as the chemotherapy solution remained in the intra‐abdominal cavity. We hypothesise that high plasma levels of cisplatin with
T. H. Schroeder +4 more
openaire +3 more sources
Hyperthermic intraperitoneal chemotherapy (HIPEC) for gynecological cancer
Journal of Obstetrics and Gynaecology Research, 2020AbstractAimHyperthermic intraperitoneal chemotherapy (HIPEC) is a method of administering anticancer agents directly while heating the abdominal cavity. The aim of this review is to know the current position of HIPEC in ovarian cancer and uterine sarcoma and its future prospects.MethodsThis article reviews the current literature and evidence for the ...
Tetsuji Kurokawa +3 more
openaire +2 more sources
Hyperthermic Intraoperative Intraperitoneal Chemotherapy Safety Considerations
AORN Journal, 1996ABSTRACTPerioperative staff members encounter many occupational exposure hazards in the workplace. Cytotoxic agent exposure is a relatively new hazard that perioperative staff members are experiencing as more surgeons use hyperthermic intraoperative intraperitoneal chemotherapy (HIIC) to treat patients with abdominopelvic cavity malignancies. Routes of
Susan K. White +2 more
openaire +2 more sources